Company Filing History:
Years Active: 2010-2012
Title: Arnaud Fontanet: Innovator in Infection Treatment
Introduction
Arnaud Fontanet is a prominent inventor based in Paris, France. He has made significant contributions to the field of infection treatment, holding 2 patents that focus on innovative methods for assessing and treating infections.
Latest Patents
Fontanet's latest patents include methods of using sIP-10, CD26 inhibitors, and CXCR3 levels in a sample to assess clearance of infection, response to interferon therapy, and treating chronic infections. The first patent relates to methods for the treatment of infection using CD26 (DPIV) inhibitors. It also involves an antibody that binds to the IP-10 protein and a method for monitoring the necessity of administering a CD26 inhibitor to a patient by evaluating levels of sIP-10, activity of CD26, and/or levels of CXCR3 cells in a sample. The second patent focuses on methods of using sIP-10 to assess HCV clearance and/or response to interferon therapy. This invention evaluates and predicts clinical outcomes in patients by measuring levels of sIP-10 protein expression, as well as therapies using sIP-10 and its fragments.
Career Highlights
Arnaud Fontanet is affiliated with the Institut Pasteur, a renowned research institution dedicated to the study of infectious diseases. His work at this prestigious institute has allowed him to explore innovative solutions to complex health challenges.
Collaborations
Fontanet has collaborated with notable colleagues, including Matthew Albert and Jeremie Decalf, to advance research in the field of infection treatment.
Conclusion
Arnaud Fontanet's contributions to the field of infection treatment through his patents and work at the Institut Pasteur highlight his role as an influential inventor. His innovative methods have the potential to significantly impact patient care and treatment outcomes.